Anastasios Gianakakos - 29 Oct 2021 Form 3 Insider Report for LianBio (LIANY)

Role
Director
Signature
By /s/ Angela Chen, Attorney-in-Fact
Issuer symbol
LIANY
Transactions as of
29 Oct 2021
Net transactions value
$0
Form type
3
Filing time
29 Oct 2021, 18:18:13 UTC
Next filing
03 Jan 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding LIAN Ordinary Shares 309,623 29 Oct 2021 By Trust

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding LIAN Stock Option (Right to Buy) 29 Oct 2021 Ordinary Shares 146,195 $6.49 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 25% of the shares underlying the option shall vest and become exercisable on the first anniversary of the commencement date, December 17, 2021; the remainder shall vest and become exercisable in 3 equal annual installments such that the option shall be fully vested on December 17, 2024, subject to the Reporting Person providing continuous service to the Issuer on each such date.

Remarks:

Exhibit List: Exhibit 24 - Power of Attorney